ESPERION THERAPEUTICS INC. - COMMON STOCK

Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023

11 نوفمبر 2023 11:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

09 نوفمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Esperion Reports Third Quarter 2023 Financial Results

07 نوفمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in Jefferies London Healthcare Conference

31 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Report Third Quarter 2023 Financial Results on November 7

24 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

12 أكتوبر 2023 09:52:25 بحسب NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

11 أكتوبر 2023 11:58:14 بحسب NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

10 أكتوبر 2023 10:02:05 بحسب NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

22 سبتمبر 2023 10:57:18 بحسب NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

21 سبتمبر 2023 13:03:54 بحسب NetDania Notify

American College of Cardiology Program to Increase Cholesterol Screenings

12 سبتمبر 2023 10:15:00 بحسب Nasdaq GlobeNewswire

Esperion to Participate in H.C. Wainwright 25th Annual Global Investment Conference

28 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at European Society of Cardiology Congress 2023

26 أغسطس 2023 11:00:00 بحسب Nasdaq GlobeNewswire

Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023

11 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 أغسطس 2023 16:15:00 بحسب Nasdaq GlobeNewswire

Esperion Reports Second Quarter 2023 Financial Results

01 أغسطس 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Report Second Quarter 2023 Financial Results on August 1

17 يوليو 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Esperion to Present Additional Data from the CLEAR Outcomes Study on CVD Prevention at the American Society for Preventive Cardiology (ASPC) Congress 2023

07 يوليو 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Esperion Announces Submission of Application for Expanded Indication with the European Medicines Agency (EMA) for NILEMDO® (bempedoic acid) Tablet and NUSTENDI® (bempedoic acid and ezetimibe) Tablet

28 يونيو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific Sessions

24 يونيو 2023 14:30:00 بحسب Nasdaq GlobeNewswire